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Abstract. Gametocytes are sexual stage malaria parasites responsible for transmission to mosquitoes. Multiple
gametocyte-producing clonesmay be present in natural infections, but themolecular characterization of gametocytes is
challenging. Because of their magnetic properties, gametocyte enrichment can be achieved by magnetic fractionation.
This increasesdetection sensitivity andallows speciﬁcgenotypingof clones that contribute tomalaria transmission.Here,
we determined the percentage of Plasmodium falciparum gametocytes successfully bound to magnetic activated cell
sorting (MACS) LS columns during magnetic fractionation and assessed whether columns can be reused without risking
contamination or affecting column binding efﬁciency. Bound column fractions were quantiﬁed using multiplex quanti-
tative reverse transcription polymerase chain reaction (qRT-PCR) formale (pfMGET) and female (CCp4) gametocytes and
ring-stage asexual parasites (SBP1). To investigate cross contamination between columns, parasite strain identity was
determined by merozoite surface protein 2 genotyping followed by capillary electrophoresis fragment sizing. A re-
producible high percentage of gametocytes was bound to MACS LS columns with < 5% gametocytes appearing in the
ﬂow-through and < 0.6% asexual ring-stage parasites appearing in the gametocyte fraction. A high yield (> 94%) of
gametocyte enrichment was achieved when columns were used up to ﬁve times with lower binding success after eight
times (79%). We observed no evidence for cross contamination between columns.
INTRODUCTION
Ongoing malaria transmission poses a considerable public
health burden in endemic countries worldwide.1 Caused by
protozoan parasites of thePlasmodium genus, six species are
able to infect human hosts on the bite of infected female
Anopheles mosquitoes. Mosquitoes are born uninfected and
may become infected after ingestion of blood meals con-
taining circulatingmature sexual stagesof theparasite, known
as gametocytes. Once ingested by the mosquito, gameto-
cytes fertilize and, following sporogonic development, pro-
duce hundreds to thousands sporozoites that migrate to the
salivary glands of the mosquito and render the mosquito in-
fectious to humans on their next bite.
Malaria transmission potential is inﬂuenced by many factors
including gametocyte density2 and several parasite factors that
determine gametocyte ﬁtness. Several studies exploited the
paramagnetic properties of gametocytes and used magnetic
column fractionation to assess gametocyte prevalence and
density in peripheral blood samples before and after antima-
larial treatment.3–6 Parasites use intraerythrocytic hemoglobin
as main protein source for development. Heme, a by-product
after digestion, is oxidized and converted in hemozoin, also
known as malaria pigment.7,8 Hemozoin accumulates over
time in infected erythrocytes and has paramagnetic proper-
ties in late-stage trophozoites, schizonts, and gametocytes.
Magnetic column fractionation can be used to increase par-
asite detectability.9 This may be particularly useful for gameto-
cytes that commonlycirculateat lowdensities,10 sometimes too
low to infect mosquitoes.11 Magnetic fractionation allows spe-
ciﬁc genotyping of asexual and gametocyte fractions to identify
the following: signatures of drug resistance,12 the number of
acquired Plasmodium clones over time (known as the force
of infection),13 the multiplicity of infection (MOI; the number of
parasite clones present in a blood sample), and which clones
contribute to malaria transmission.14 Although molecular de-
tection of gametocytes without magnetic concentration is
possible and operationally attractive in well-equipped labora-
tories, it has limitations in terms of the genetic characterization
of gametocytes because gametocytes only comprise a small
fraction of the total parasite biomass and there are few suitable
polymorphic gametocyteRNA targets.15Assessinggametocyte
MOI and resistance markers is of interest because MOI may
affect transmission success16,17 and drug-resistant parasite
clones may have a transmission advantage compared with
wild-type parasites.18
In the present study, MACS cell separation columns based
on magnetic binding were used to capture mature gameto-
cytes and separate these from asexual parasites. Concen-
trated gametocytes were used to quantify their density and
assess their molecular signature. To make the assay more
attractive for large-scale studies, a procedure to wash and
reuse columnswas validated in terms of gametocyte yield and
risks of contamination. For quantiﬁcation, a qRT-PCR was
used to quantify messenger RNA from asexual parasite rings
(SBP1) and male (pfMGET) and female (CCp4) gametocyte-
speciﬁc genes.19,20 Parasite strain identity was determined by
merozoite surface protein 2 (MSP2) genotyping followed by
capillary electrophoresis (CE) fragment sizing.21,22
MATERIALS AND METHODS
Culture, synchronizing, and dilution of Plasmodium fal-
ciparumparasites.An automated culture systemwas used23
to culture the Nijmegen falciparum (NF) 54 (West-Africa),
NF135 (Cambodia), and a previously not presented NF175
(Nigeria) strain.24,25 The medium was replaced automatically
twice a day and asexual replication was maintained by
suspension of 0.5% parasites in 5% red blood cells every
2–3 days. Cultures were ring synchronized with 5% sorbitol
in H2O. For gametocyte production, asynchronous cultures
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were started onday 0 (0.5%parasites, 5% redblood cells) and
treated with N-acetyl-glucosamine (50 mM; Sigma Aldrich,
Darmstadt, Germany) from day 9 to 14 to stop off asexual par-
asite replication. Cultures were harvested at day 16 (0.3–0.5%
gametocytes and 2% hematocrit).
For asexual parasite cultures, Giemsa’s stained blood
smears were made to determine the percentage of infectivity
(Supplemental Figure 1). A 100 times dilution of culturematerial
in phosphate buffered saline (PBS) (1×) was made to count the
number of erythrocytes with a hemocytometer. The equivalent
volume for 70,000 ring-stage parasites per μL was added to
0.5 mL of peripheral fresh collected ethylenediaminetriacetric
acid (EDTA) blood (Becton Dickinson, Vacutainer system).
For N-acetyl-glucosamine–treated gametocyte cultures,
blood smears were Giemsa stained at day 16 to conﬁrm the
absence of asexual parasites and presence of stage ﬁve ga-
metocytes (Figure 1). No evidence of gametocyte activation
(exﬂagellating or the production of female round forms) was
observed in any of the slides examined. The total number of
gametocytes per milliliter culture was counted with a hemocy-
tometer. The equivalent volume of the desired end concentra-
tion was transferred to a 15 mL tube. Tubes were spun down
(2,000 rpm, 5 minutes) and supernatant was removed; a vol-
ume of 2.5mLwas left behind. Subsequently, 0.5mL preheated
uninfected EDTA blood was added.
MACS procedure and washing of columns. The
QuadroMACS separator (Miltenyi Biotec, Bergisch Glad-
bach, Germany) with LS columns was used, inside a 37C
incubator, to capture gametocyte-infected red blood cells.
All to be used materials were preheated to 37C. A 25G hy-
podermic needle (Becton Dickinson, Franklin Lakes, NJ) was
attached to each column to reduce ﬂow speed to 0.67mL per
minute (Supplemental Figure 2A and B). Up to four columns
were attached to the MultiStand and 15 mL tubes were
placed underneath to collect ﬂow-through material. To hy-
drate the columns, 1 mL of Roswell Park Memorial Institute
(RPMI) medium was added (Supplemental Figure 2C and D)
and after the ﬂow ceased, a premix of 2.5 mL RPMI with
0.5 mL of infected or uninfected peripheral EDTA blood was
added (Supplemental Figure 2E). After all material ﬂowed
through (Supplemental Figure 2F and G), columns were
washed two times with 1 mL of RPMI medium to remove un-
bound cells (Supplemental Figure 2H and I). Needles were
removed and columns were detached from the MultiStand
and transferred to new 15 mL tubes. Two times 1 mL of RPMI
medium was added to the columns to elute bound material.
After the ﬂow ceased, the plunger was used to remove the last
remainingmedium. All tubes, bound fraction and ﬂow-through
fraction, were spun down at 2,000 rpm in a prewarmed 37C
centrifuge. The supernatant was removed and ﬁve times the
equal volume of RNA protect was added (Qiagen, Hilden,
Germany). The sample was frozen at −80C to be extracted
later.
For reusage experiments, columns were washed ﬁve con-
secutive times with distilled water and the plunger was used
each time to ﬂush out the water. This procedure was repeated
ﬁve times with 70% ethanol. Washed columns were dried over-
night in an incubator at 37C and reused the following day.
Parasites quantiﬁcation and identiﬁcation by MSP2
genotyping and qRT-PCR. Total nucleic acid (NA) was
extracted with the automated MagNA Pure LC instrument
(Roche, Basel, Switzerland) using the MagNA Pure LC Total
Nucleic Acid Isolation Kit—High Performance (Roche) and
eluted in 50 μL. Samples were used immediately or stored
at −20C for long term storage. To distinguish parasites mo-
lecularly, the single copypolymorphicMSP2genewasused for
genotyping. In a nested PCR, ﬁrst the entire MSP2 gene seg-
mentwas ampliﬁed and subsequently used to amplify the allele
FIGURE 1. Stained blood smears of bound and ﬂow-through fraction. Images areGiemsa’s stainedblood smears using lightmicroscopy at 1,000
magniﬁcation. Thick smear and blood smear of bound fraction (A + B) and ﬂow-through fraction (C + D).
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strain-speciﬁc gene variant type FC27 or 3D7.26 Fluorescently
labeled primers were used to enable laser detection after cap-
illary gel electrophoresis; Peak Scanner version 2 software
(Applied Biosystem, Foster City, CA) was used for automated
fragment sizing.21,22
For parasite quantiﬁcation, isolated messenger RNA (mRNA)
was used in a qRT-PCR multiplex assay for pfMGET (males)
and CCp4 (females) transcripts for the gametocytes27,28; a
separate qRT-PCR was used for asexual parasites (SBP1).20
MACS column binding efﬁciency of cultured gameto-
cytes, with and without asexual ring stages. To determine
the binding efﬁciency of MACS columns, a 10-fold serial di-
lution of NF54 gametocyte culture material was made in
0.5 mL of peripheral EDTA blood in triplicate (gametocyte
starting conc. 4,000/μL). The column bound fraction and ﬂow-
through fraction were collected for qRT-PCR analysis. In an
identical experimental setup, 70,000/μL NF54 asexual ring-
stage parasites were added to each of the serial dilution
samples to mimic a natural infection (gametocyte start conc.
10,000/μL). The column bound fraction and ﬂow-through
fraction were collected for qRT-PCR analysis.
Validating reusage of MACS columns by MSP2 geno-
typing and qRT-PCR. In a three-way approach, we tested
whether columns canbe reusedwithout risking contamination
or affecting column binding efﬁciency.
In the ﬁrst set, new columns were used to capture 10,000
gametocytes/μL cultured NF54 gametocytes in a total volume
of 0.5 mL of peripheral EDTA blood per column. The column
bound fractions and ﬂow-through fractions were collected for
MSP2 analysis. Columns were reused the following day after
washing procedure and 0.5 mL uninfected EDTA blood was
run as a negative control. Samples were collected for MSP2
analysis. The procedure was repeated for a second (NF135)
and third strain (NF175), all performed in triplicate.
In the second set, new columns were used to capture 10,000
gametocytes/μL in 0.5mLof peripheral EDTAblood. In triplicate,
the NF54, NF135, and NF175 strains were processed on the
samecolumn,withwashing inbetween.Thebound fractionsand
ﬂow-through fractions were collected for MSP2 analysis.
For the third set, a newcolumnwasused to capture cultured
NF54 gametocytes in a total volume of 0.5 mL of peripheral
EDTA blood. Bound fractions and ﬂow-through fractionswere
collected for qRT-PCR analysis. Columns were washed, and
the next day, the same procedurewas repeatedwith 0.5mL of
uninfected EDTA blood as negative control. Samples were
collected for qRT-PCR analysis and the whole procedure was
performed another four times.
Analysis. Merozoite surface protein 2 analysis of samples
was initially performed by running an agarose gel to visualize
positive and negative samples from nested PCR products. All
the products were subsequently processed by CE and different
MSP2 alleles analyzed by Peak Scanner software. Size, dye
color, and height were used to deﬁne the different alleles in the
3D7 and FC27 families.
For qRT-PCR, the number of parasites per milliliter was
calculated with a standard curve, obtained using 10-fold di-
lutions of cultured gametocytes (for CCP4 and pfMGET) or
asexual parasites (for SBP1) (Supplemental Figure 3).
RESULTS
Cultured gametocytes are retained with high yield by
MACS columns. To determine the efﬁciency of parasite
binding onMACScolumns, two 10-fold serial dilutionswith ﬁve
concentrations were made in triplicate with starting concen-
trations of 4,000 gametocytes/μL (I) and 10,000 gametocytes/
μL (II) and quantiﬁed by qRT-PCR. Both showed excellent
agreement between estimated parasite density by serial di-
lution and qRT-PCR (mean R2 0.995, range 0.984–0.999).
To demonstrate binding efﬁciency, the quantiﬁed gameto-
cytes in the bound and ﬂow-through fractions were shown in
percentages (Figure 2A) and absolute numbers (Figure 2B).
For dilution I, the mean proportion of gametocytes that were
bound was 99.11% (n = 15, range 89.02–100, SD 2.8) and the
mean proportion of gametocytes that were detected in the un-
bound ﬂow-through fraction was 0.886% (n = 15, range 0–10.98,
SD2.8). For dilution II, themeanproportionswere 96.33%(n=14,
range 82.71–99.86, SD 4.77) and 3.673% (n = 14, range
0.14–17.29, SD 4.77), respectively. In dilution II, asexual ring-
stage parasites were added to the infected blood at a con-
centration of 70,000 par/μL tomimic a natural infection density
(Figure 2A). The proportions of ring-stage parasites in the bound
FIGURE 2. MACS column gametocyte and asexual ring stages binding efﬁciency quantiﬁed by qRT-PCR. Themean percentage of gametocytes
andasexual parasitesappearing in thebound fractionor ﬂow-through fraction is shown for two independent serial dilutions thatwerebothexamined
in triplicate. Starting concentrations for series I and II were 4,000and10,000gametocytes/μL, respectively. PanelA showsparasite populations as a
fraction of the input material and panel B shows the total number of gametocytes per μL for the bound fraction (solid line) or ﬂow-through fraction
(dotted line) of series I (circles) and II (triangles).
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column fraction and ﬂow-through fraction were 0.64% (n = 14,
range 0.23–0.946, SD 0.215) and 99.36% (n = 14, range
99.05–99.77, SD 0.215), respectively.
Cross contamination and binding efﬁciency when MACS
columns are reused. To investigate cross contamination in
reused columns, we ﬁrst performed experiments where a
column was used to bind gametocytes, washed, and sub-
sequently used with infected or uninfected blood. Three
genetically distinct parasite lines showed distinguishable
MSP2 PCR products after gel electrophoresis (Figure 3) and
CE (Supplemental Tables 1 and 2), conﬁrming the expected
parasite genotype in bound fractions. Of the experiments
with infected–uninfected blood, one sample showed PCR-
detectable parasite material (Supplemental Table 1). A total
of 17 of 18 analyzed samples thus had matching results. In
the experiments that repeatedly used infected blood, all gel
electrophoresis results matched the expected result (9/9), but
CE failed for one sample (8/9 matching results) (Supplemental
Table 2).
To investigate the binding efﬁciency and potential contami-
nation following reusing of columns, gametocyte qRT-PCRwas
performed to determine the number of gametocytes present in
the bound fraction and ﬂow-through fraction. Columns were
used up to 10 times, alternating positive gametocyte samples
on 1 day and negative blood samples on the next day. Columns
were washed in between, and dried overnight to be used the
following day. The binding efﬁciencies of the columns for the
positivesamplesover timewereas follows:Run1.mean94.01%
(n = 3, range 86.17–99.59, SD 6.99), Run 3. mean 98.24% (n =
2, range 97.63–98.85, SD 0.86), Run 5. mean 98.46% (n = 3,
range96.96–99.41,SD1.317),Run7.mean94.04%(n=3, range
86.06–98.48, SD 6.93), and Run 9. mean 78.90% (n = 3, range
71.04–88.17, SD 8.65). Runs 2, 4, 5, 8, and 10 were performed
with negative blood and were negative by qRT-PCR (Figure 4).
The number of bound gametocytes is given in the legend of
Figure 4.
DISCUSSION
The aims of this study were to determine the proportion of
P. falciparum gametocytes successfully bound to MACS LS
columns duringmagnetic fractionation and to assess whether
columns can be reused without risking contamination or af-
fecting column binding efﬁciency.
Our ﬁndings demonstrate that a high percentage of game-
tocytes is bound toMACS LS columnswith < 5%gametocyte
appearing in the ﬂow-through. Karl et al.29 previously reported
no variation between P. falciparum parasite strains in MACS
binding capacity and efﬁcient binding at densities less than 1
gametocyte/μL.30 In the present study, we complement these
ﬁndings and mimic natural infections, where gametocytes
typically comprise < 10% of the total parasite biomass,10 by
adding an excess of asexual ring-stage parasites to our ga-
metocytematerial. Ring-stage asexual parasites are themajor
other parasite stage in the circulation, schizonts being ob-
served very rarely in the peripheral blood of malaria patients
andmostly in severe caseswith veryhighparasite burden.31,32
As expected, only a small proportion of rings (0.6%)was found
in the bound fraction without a disadvantageous inﬂuence of
asexual parasites on the gametocyte binding efﬁciency of
columns. A small proportion of young-stage schizonts that
survived sorbitol treatment was observed in Giemsa’s stained
smears with a ring/schizont ratio of 150:1 (0.67%) and may
have been responsible for the low-level binding of asexual
parasites to the column. From this, we conclude that con-
centrating gametocytes up to 10,000 parasites/μL per 0.5 mL
of peripheral blood is highly efﬁcient and very reproducible.
This supplements previous reports that the highest capture
efﬁciencies are achieved at a minimal ﬂow rate and minimal
concentration of infected cells and large blood volumes are
not affecting gametocyte binding efﬁciency.29 Our detection
of male and female gametocytes suggests that also gameto-
cyte sex ratio can be sensitively assessed following MACS
enrichment; we found no evidence for a loss of exﬂagellating
male gametocytes during the MACS procedures that could
have distorted sex ratio assessments.
Reusage of columns is operationally and ﬁnancially attrac-
tive, especially for ﬁeld laboratories. In the present study, high
gametocyte quantities were processed on MACS columns
with intermediate washing steps. Collected bound gameto-
cyte fractions were analyzed by MSP2 PCR and gel/CE to
identify potential cross contamination. For gel electrophore-
sis, 26 of 27 samples matched expected results, and for CE,
25 of 27 samples. Failures were plausibly due to a incidental
error in the washing procedure or contamination during DNA
isolation and a technical failure in CE. In the multiplex qRT-
PCR, we observed a consistent high yield of gametocytes
(> 94%) when columns were used up to ﬁve times but lower
binding success after eight times (79%). There was a reduced
ﬂow speed after usage of the column ﬁve times and a few dots
of rust appearing after usage of seven times, but this had no
apparent inﬂuence on the binding efﬁciency.
FIGURE 3. Merozoite surface protein (MSP2) MACS-bound column fraction results for infected and uninfected blood with overnight column
washing in between. Gel electrophoresis image results of MSP2 genotyping from collected bound column fractions. Nijmegen falciparum (NF)-54,
NF135, and NF175 can be can be distinguished on difference in fragment size. All negative samples run with uninfected blood were negative, and
show no result on gel.
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Our ﬁndings build on earlier observations that magnetic
fractionation of blood from natural infections can increase the
sensitivity of gametocyte detection30,33 and that it is highly
challenging to characterize gametocyte producing clones
based on polymorphic mRNA targets.15 In the present study,
we demonstrated that magnetic fractionation may be used to
overcome this problem by concentrating gametocytes from
(large) blood volumes and subsequent conventional geno-
typing approaches. This enables the detection of gametocyte
clonal complexity14 and potentially a more detailed examina-
tion of gametocyte production in relation to antimalarial drug
resistance.34 The latter may be particularly relevant because
antimalarial drug resistance may differentially impact asexual
parasite survival, gametocyte production and transmission,35–37
and sensitively examining the molecular signatures in asexual,
and gametocyte fractions may thus help in understanding how
drug-resistant parasites spread and respond to drug pressure.
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